| MiR‐634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf‐ERK signaling pathway | |
| Tan, Zhigang; Zhao, Jizong; Jiang, Yugang* | |
| 刊名 | Cancer Medicine
 |
| 2018 | |
| 卷号 | 7期号:3页码:913-921 |
| 关键词 | Drug resistance glioma microRNA signaling temozolomide |
| ISSN号 | 2045-7634 |
| DOI | 10.1002/cam4.1351 |
| URL标识 | 查看原文 |
| WOS记录号 | WOS:000427562600036 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3345283 |
| 专题 | 中南大学 |
| 作者单位 | 1.[Tan, Zhigang 2.Jiang, Yugang] Cent S Univ, Xiangya Hosp 2, Dept Neurosurg, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China. |
| 推荐引用方式 GB/T 7714 | Tan, Zhigang,Zhao, Jizong,Jiang, Yugang*. MiR‐634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf‐ERK signaling pathway[J]. Cancer Medicine,2018,7(3):913-921. |
| APA | Tan, Zhigang,Zhao, Jizong,&Jiang, Yugang*.(2018).MiR‐634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf‐ERK signaling pathway.Cancer Medicine,7(3),913-921. |
| MLA | Tan, Zhigang,et al."MiR‐634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf‐ERK signaling pathway".Cancer Medicine 7.3(2018):913-921. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论